Ajay Dhankhar
Smith+Nephew (NYSE: SNN) has announced the appointment of Ajay Dhankhar as its new chief corporate development & strategy officer.
Dhankhar, who reports to CEO Deepak Nath, will also join Smith+Nephew’s executive committee, the company announced on June 23.
“As both a senior management consultant and investment banker, Ajay has advised CEOs and boards at some of the world’s leading health-care companies, helping deliver substantial shareholder value,” the announcement said. “Ajay’s experience includes 25 years with McKinsey & Company, where he was a senior partner and held multiple leadership roles, including global head of strategy across all industries, global head of strategy and M&A for Life Sciences, and global head of Life Sciences R&D.”
More recently, Smith+Nephew added, Dhankhar founded and led Bluish Capital, described as a financial advisory firm that focused on deploying growth capital to support assets recently approved by the U.S. Food & Drug Administration.
“Ajay’s unique blend of scientific rigor, strategic insight, business development, integrations and operational excellence, combined with his entrepreneurial leadership style, makes him exceptionally well-suited to help shape our future,” Nath said. “We are pleased to have him join our leadership team at this exciting time for the company.”
Smith+Nephew’s medical device portfolio includes products for wound care and negative pressure wound therapy. The company is based in Watford, England, with American offices in Andover, Massachusetts.
